The FDA says shortages of GLP-1s are over, but many patients are still getting what are essentially copied medications.

Novo Nordisk faces a critical phase with its obesity drug Wegovy as it confronts competition from Eli Lilly and potential job ...

RFK Jr. announced that the U.S. government’s emergency preparedness agency will no longer fund work on mRNA vaccines ...

Experts reveal potential side effect of Ozempic – and whether we should worry - Researchers found Ozempic-induced weight loss decreased muscle mass by about 10 per cent ...